Anticoagulants Market Size, Share, Growth, and Forecast 2032
Anticoagulants Market By Drug Class (NOACs, Heparin & LMWH, Vitamin K Antagonist, And Others), By Route Of Administration (Injectable Anticoagulant And Oral Anticoagulant), By Application (Stroke, Atrial Fibrillation, Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), And Others), By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 43.28 Billion | USD 97.16 Billion | 9.4% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global Anticoagulants market, 2016-2025 (USD Billion)
- 2.2. Global Anticoagulants market: Snapshot
- Chapter 3. Anticoagulants Market - Industry Dynamics
- 3.1. Introduction
- 3.2. Market drivers
- 3.2.1. Growing incidences of cardiovascular disorders and venous thromboembolism (VTE)
- 3.2.2. The increasing acceptance of novel oral anticoagulants (NOACs)
- 3.3. Market Restraints
- 3.3.1. The higher rate of NOACs
- 3.3.2. The existence of alternative drugs
- 3.4. Opportunities
- 3.4.1. Increasing investment by the leading market players
- 3.4.2. High unmet needs
- 3.5. Porter's Five Forces Analysis
- 3.6. Market attractiveness analysis
- 3.6.1. Market attractiveness analysis, by Drug Class
- 3.6.2. Market attractiveness analysis, by Route of Administration
- 3.6.3. Market attractiveness analysis, by Application
- 3.6.4. Market attractiveness analysis, by Region
- Chapter 4. Global Anticoagulants market - Competitive Landscape
- 4.1. Company Market Share Analysis
- 4.1.1. Global Anticoagulants market: company market share, 2018
- 4.2. Strategic Development
- 4.2.1. Acquisitions & Mergers
- 4.2.2. New Product Launch
- 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
- 4.2.4. Research and Development and Regional Expansion
- 4.1. Company Market Share Analysis
- Chapter 5. Global Anticoagulants market - Drug Class Analysis
- 5.1. Global Anticoagulants market: Drug Class overview
- 5.1.1. Global Anticoagulants market revenue share, by Drug Class, 2018 and 2025
- 5.2. NOACs
- 5.2.1. Global Anticoagulants market for NOACs, 2016-2025 (USD Billion)
- 5.3. Heparin & LMWH
- 5.3.1. Global Anticoagulants market for Heparin & LMWH, 2016-2025 (USD Billion)
- 5.4. Vitamin K Antagonist
- 5.4.1. Global Anticoagulants market for Vitamin K Antagonist, 2016-2025 (USD Billion)
- 5.5. Others
- 5.5.1. Global Anticoagulants market for Others, 2016-2025 (USD Billion)
- 5.1. Global Anticoagulants market: Drug Class overview
- Chapter 6. Global Anticoagulants market - Route of Administration Analysis
- 6.1. Global Anticoagulants market: Route of Administration overview
- 6.1.1. Global Anticoagulants market revenue share, by Route of Administration, 2018 and 2025
- 6.2. Injectable Anticoagulant
- 6.2.1. Global Anticoagulants market for Injectable Anticoagulant, 2016-2025 (USD Billion)
- 6.3. Oral Anticoagulant
- 6.3.1. Global Anticoagulants market for Oral Anticoagulant, 2016-2025 (USD Billion)
- 6.1. Global Anticoagulants market: Route of Administration overview
- Chapter 7. Global Anticoagulants market - Application Analysis
- 7.1. Global Anticoagulants market: Application overview
- 7.1.1. Global Anticoagulants market revenue share, by Application, 2018 and 2025
- 7.2. Stroke
- 7.2.1. Global Anticoagulants market for Stroke, 2016-2025 (USD Billion)
- 7.3. Atrial Fibrillation
- 7.3.1. Global Anticoagulants market for Atrial Fibrillation, 2016-2025 (USD Billion)
- 7.4. Pulmonary Embolism (PE)
- 7.4.1. Global Anticoagulants market for Pulmonary Embolism (PE), 2016-2025 (USD Billion)
- 7.5. Deep vein thrombosis (DVT)
- 7.5.1. Global Anticoagulants market for Deep vein thrombosis (DVT), 2016-2025 (USD Billion)
- 7.6. Others
- 7.6.1. Global Anticoagulants market for Others, 2016-2025 (USD Billion)
- 7.1. Global Anticoagulants market: Application overview
- Chapter 8. Global Anticoagulants market - Regional Analysis
- 8.1. Global Anticoagulants market: Regional overview
- 8.1.1. Global Anticoagulants market revenue share, by region, 2018 and 2025
- 8.2. North America
- 8.2.1. North America Anticoagulants market revenue, by Drug Class, 2016-2025 (USD Billion)
- 8.2.2. North America Anticoagulants market revenue, by Route of Administration, 2016-2025 (USD Billion)
- 8.2.3. North America Anticoagulants market revenue, by Application, 2016-2025 (USD Billion)
- 8.2.4. The U.S.
- 8.2.4.1. The U.S. Anticoagulants market revenue, by Drug Class, 2016-2025 (USD Billion)
- 8.2.4.2. The U.S. Anticoagulants market revenue, by Route of Administration, 2016-2025 (USD Billion)
- 8.2.4.3. The U.S. Anticoagulants market revenue, by Application, 2016-2025 (USD Billion)
- 8.2.5. Rest of North America
- 8.2.5.1. Rest of North America Anticoagulants market revenue, by Drug Class, 2016-2025 (USD Billion)
- 8.2.5.2. Rest of North America Anticoagulants market revenue, by Route of Administration, 2016-2025 (USD Billion)
- 8.2.5.3. Rest of North America Anticoagulants market revenue, by Application, 2016-2025 (USD Billion)
- 8.3. Europe
- 8.3.1. Europe Anticoagulants market revenue, by Drug Class, 2016-2025 (USD Billion)
- 8.3.2. Europe Anticoagulants market revenue, by Route of Administration, 2016-2025 (USD Billion)
- 8.3.3. Europe Anticoagulants market revenue, by Application, 2016-2025 (USD Billion)
- 8.3.4. Germany
- 8.3.4.1. Germany Anticoagulants market revenue, by Drug Class, 2016-2025 (USD Billion)
- 8.3.4.2. Germany Anticoagulants market revenue, by Route of Administration, 2016-2025 (USD Billion)
- 8.3.4.3. Germany Anticoagulants market revenue, by Application, 2016-2025 (USD Billion)
- 8.3.5. U.K.
- 8.3.5.1. U.K. Anticoagulants market revenue, by Drug Class, 2016-2025 (USD Billion)
- 8.3.5.2. U.K. Anticoagulants market revenue, by Route of Administration, 2016-2025 (USD Billion)
- 8.3.5.3. U.K. Anticoagulants market revenue, by Application, 2016-2025 (USD Billion)
- 8.3.6. France
- 8.3.6.1. France Anticoagulants market revenue, by Drug Class, 2016-2025 (USD Billion)
- 8.3.6.2. France Anticoagulants market revenue, by Route of Administration, 2016-2025 (USD Billion)
- 8.3.6.3. France Anticoagulants market revenue, by Application, 2016-2025 (USD Billion)
- 8.3.7. Rest of Europe
- 8.3.7.1. Rest of Europe Anticoagulants market revenue, by Drug Class, 2016-2025 (USD Billion)
- 8.3.7.2. Rest of Europe Anticoagulants market revenue, by Route of Administration, 2016-2025 (USD Billion)
- 8.3.7.3. Rest of Europe Anticoagulants market revenue, by Application, 2016-2025 (USD Billion)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Anticoagulants market revenue, by Drug Class, 2016-2025 (USD Billion)
- 8.4.2. Asia Pacific Anticoagulants market revenue, by Route of Administration, 2016-2025 (USD Billion)
- 8.4.3. Asia Pacific Anticoagulants market revenue, by Application, 2016-2025 (USD Billion)
- 8.4.4. China
- 8.4.4.1. China Anticoagulants market revenue, by Drug Class, 2016-2025 (USD Billion)
- 8.4.4.2. China Anticoagulants market revenue, by Route of Administration, 2016-2025 (USD Billion)
- 8.4.4.3. China Anticoagulants market revenue, by Application, 2016-2025 (USD Billion)
- 8.4.5. Japan
- 8.4.5.1. Japan Anticoagulants market revenue, by Drug Class, 2016-2025 (USD Billion)
- 8.4.5.2. Japan Anticoagulants market revenue, by Route of Administration, 2016-2025 (USD Billion)
- 8.4.5.3. Japan Anticoagulants market revenue, by Application, 2016-2025 (USD Billion)
- 8.4.6. India
- 8.4.6.1. India Anticoagulants market revenue, by Drug Class, 2016-2025 (USD Billion)
- 8.4.6.2. India Anticoagulants market revenue, by Route of Administration, 2016-2025 (USD Billion)
- 8.4.6.3. India Anticoagulants market revenue, by Application, 2016-2025 (USD Billion)
- 8.4.7. Rest of Asia Pacific
- 8.4.7.1. Rest of Asia Pacific Anticoagulants market revenue, by Drug Class, 2016-2025 (USD Billion)
- 8.4.7.2. Rest of Asia Pacific Anticoagulants market revenue, by Route of Administration, 2016-2025 (USD Billion)
- 8.4.7.3. Rest of Asia Pacific Anticoagulants market revenue, by Application, 2016-2025 (USD Billion)
- 8.5. Latin America
- 8.5.1. Latin America Anticoagulants market revenue, by Drug Class, 2016-2025 (USD Billion)
- 8.5.2. Latin America Anticoagulants market revenue, by Route of Administration, 2016-2025 (USD Billion)
- 8.5.3. Latin America Anticoagulants market revenue, by Application, 2016-2025 (USD Billion)
- 8.5.4. Brazil
- 8.5.4.1. Brazil Anticoagulants market revenue, by Drug Class, 2016-2025 (USD Billion)
- 8.5.4.2. Brazil Anticoagulants market revenue, by Route of Administration, 2016-2025 (USD Billion)
- 8.5.4.3. Brazil Anticoagulants market revenue, by Application, 2016-2025 (USD Billion)
- 8.5.5. Rest of Latin America
- 8.5.5.1. Rest of Latin America Anticoagulants market revenue, by Drug Class, 2016-2025 (USD Billion)
- 8.5.5.2. Rest of Latin America Anticoagulants market revenue, by Route of Administration, 2016-2025 (USD Billion)
- 8.5.5.3. Rest of Latin America Anticoagulants market revenue, by Application, 2016-2025 (USD Billion)
- 8.6. The Middle East and Africa
- 8.6.1. The Middle East and Africa Anticoagulants market revenue, by Drug Class, 2016-2025 (USD Billion)
- 8.6.2. The Middle East and Africa Anticoagulants market revenue, by Route of Administration, 2016-2025 (USD Billion)
- 8.6.3. The Middle East and Africa Anticoagulants market revenue, by Application, 2016-2025 (USD Billion)
- 8.1. Global Anticoagulants market: Regional overview
- Chapter 9. Company Profile
- 9.1. Bayer AG
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Product portfolio
- 9.1.4. Business strategy
- 9.1.5. Recent developments
- 9.2. Aspen Holdings
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Product portfolio
- 9.2.4. Business strategy
- 9.2.5. Recent developments
- 9.3. Boehringer Ingelheim GmbH
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Product portfolio
- 9.3.4. Business strategy
- 9.3.5. Recent developments
- 9.4. Daiichi Sankyo Company, Limited
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Product portfolio
- 9.4.4. Business strategy
- 9.4.5. Recent developments
- 9.5. Bristol-Myers Squibb Company
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Product portfolio
- 9.5.4. Business strategy
- 9.5.5. Recent developments
- 9.6. GlaxoSmithKline
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Product portfolio
- 9.6.4. Business strategy
- 9.6.5. Recent developments
- 9.7. Pfizer, Inc.
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Product portfolio
- 9.7.4. Business strategy
- 9.7.5. Recent developments
- 9.8. Sanofi S.A.
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Product portfolio
- 9.8.4. Business strategy
- 9.8.5. Recent developments
- 9.9. Johnson & Johnson
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Product portfolio
- 9.9.4. Business strategy
- 9.9.5. Recent developments
- 9.10. Portola Pharmaceuticals, Inc.
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Product portfolio
- 9.10.4. Business strategy
- 9.10.5. Recent developments
- 9.1. Bayer AG
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Anticoagulants market revenue, 2016–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Anticoagulants market attractiveness analysis, by Drug Class
6. Anticoagulants market attractiveness analysis, by Route of Administration
7. Anticoagulants market attractiveness analysis, by Application
8. Anticoagulants: Market attractiveness analysis, by Region
9. Company market share analysis, 2018
10. Global Anticoagulants market revenue share by Drug Class, 2018 and 2025
11. Global Anticoagulants market for NOACs, 2016–2025 (USD Billion)
12. Global Anticoagulants market for Heparin & LMWH, 2016–2025 (USD Billion)
13. Global Anticoagulants market for Vitamin K Antagonist, 2016–2025 (USD Billion)
14. Global Anticoagulants market for Others, 2016–2025 (USD Billion)
15. Global Anticoagulants market revenue share by Route of Administration, 2018 and 2025
16. Global Anticoagulants market for Injectable Anticoagulant, 2016–2025 (USD Billion)
17. Global Anticoagulants market for Oral Anticoagulant, 2016–2025 (USD Billion)
18. Global Anticoagulants market by Application, 2016–2025 (USD Billion)
19. Global Anticoagulants market for Stroke, 2016–2025 (USD Billion)
20. Global Anticoagulants market for Atrial Fibrillation, 2016–2025 (USD Billion)
21. Global Anticoagulants market for Pulmonary Embolism (PE), 2016–2025 (USD Billion)
22. Global Anticoagulants market for Deep vein thrombosis (DVT), 2016–2025 (USD Billion)
23. Global Anticoagulants market for Others, 2016–2025 (USD Billion)
24. North America Anticoagulants market, 2016–2025 (USD Billion)
25. Europe Anticoagulants market, 2016–2025 (USD Billion)
26. Asia Pacific Anticoagulants market, 2016–2025 (USD Billion)
27. Latin America Anticoagulants market, 2016–2025 (USD Billion)
28. The Middle East and Africa Anticoagulants market, 2016–2025 (USD Billion)
Table Of Tables
List of Tables
1. Anticoagulants market: Market Snapshot
2. Drivers of global Anticoagulants market: Impact analysis
3. Restraints of global Anticoagulants market: Impact analysis
4. Opportunities of global Anticoagulants market: Impact analysis
5. North America Anticoagulants market revenue, by Drug Class, 2016–2025 (USD Billion)
6. North America Anticoagulants market revenue, by Route of Administration, 2016–2025 (USD Billion)
7. North America Anticoagulants market revenue, by Application, 2016–2025 (USD Billion)
8. The U.S. Anticoagulants market revenue, by Drug Class, 2016–2025 (USD Billion)
9. The U.S. Anticoagulants market revenue, by Route of Administration, 2016–2025 (USD Billion)
10. The U.S. Anticoagulants market revenue, by Application, 2016–2025 (USD Billion)
11. Rest of North America Anticoagulants market revenue, by Drug Class, 2016–2025 (USD Billion)
12. Rest of North America Anticoagulants market revenue, by Route of Administration, 2016–2025 (USD Billion)
13. Rest of North America Anticoagulants market revenue, by Application, 2016–2025 (USD Billion)
14. Europe Anticoagulants market revenue, by Drug Class, 2016–2025 (USD Billion)
15. Europe Anticoagulants market revenue, by Route of Administration, 2016–2025 (USD Billion)
16. Europe Anticoagulants market revenue, by Application, 2016–2025 (USD Billion)
17. Germany Anticoagulants market revenue, by Drug Class, 2016–2025 (USD Billion)
18. Germany Anticoagulants market revenue, by Route of Administration, 2016–2025 (USD Billion)
19. Germany Anticoagulants market revenue, by Application, 2016–2025 (USD Billion)
20. U.K. Anticoagulants market revenue, by Drug Class, 2016–2025 (USD Billion)
21. U.K. Anticoagulants market revenue, by Route of Administration, 2016–2025 (USD Billion)
22. U.K. Anticoagulants market revenue, by Application, 2016–2025 (USD Billion)
23. France Anticoagulants market revenue, by Drug Class, 2016–2025 (USD Billion)
24. France Anticoagulants market revenue, by Route of Administration, 2016–2025 (USD Billion)
25. France Anticoagulants market revenue, by Application, 2016–2025 (USD Billion)
26. Rest of Europe Anticoagulants market revenue, by Drug Class, 2016–2025 (USD Billion)
27. Rest of Europe Anticoagulants market revenue, by Route of Administration, 2016–2025 (USD Billion)
28. Rest of Europe Anticoagulants market revenue, by Application, 2016–2025 (USD Billion)
29. Asia Pacific Anticoagulants market revenue, by Drug Class, 2016–2025 (USD Billion)
30. Asia Pacific Anticoagulants market revenue, by Route of Administration, 2016–2025 (USD Billion)
31. Asia Pacific Anticoagulants market revenue, by Application, 2016–2025 (USD Billion)
32. China Anticoagulants market revenue, by Drug Class, 2016–2025 (USD Billion)
33. China Anticoagulants market revenue, by Route of Administration, 2016–2025 (USD Billion)
34. China Anticoagulants market revenue, by Application, 2016–2025 (USD Billion)
35. Japan Anticoagulants market revenue, by Drug Class, 2016–2025 (USD Billion)
36. Japan Anticoagulants market revenue, by Route of Administration, 2016–2025 (USD Billion)
37. Japan Anticoagulants market revenue, by Application, 2016–2025 (USD Billion)
38. India Anticoagulants market revenue, by Drug Class, 2016–2025 (USD Billion)
39. India Anticoagulants market revenue, by Route of Administration, 2016–2025 (USD Billion)
40. India Anticoagulants market revenue, by Application, 2016–2025 (USD Billion)
41. Rest of Asia Pacific Anticoagulants market revenue, by Drug Class, 2016–2025 (USD Billion)
42. Rest of Asia Pacific Anticoagulants market revenue, by Route of Administration, 2016–2025 (USD Billion)
43. Rest of Asia Pacific Anticoagulants market revenue, by Application, 2016–2025 (USD Billion)
44. Latin America Anticoagulants market revenue, by Drug Class, 2016–2025 (USD Billion)
45. Latin America Anticoagulants market revenue, by Route of Administration, 2016–2025 (USD Billion)
46. Latin America Anticoagulants market revenue, by Application, 2016–2025 (USD Billion)
47. Brazil Anticoagulants market revenue, by Drug Class, 2016–2025 (USD Billion)
48. Brazil Anticoagulants market revenue, by Route of Administration, 2016–2025 (USD Billion)
49. Brazil Anticoagulants market revenue, by Application, 2016–2025 (USD Billion)
50. Rest of Latin America Anticoagulants market revenue, by Drug Class, 2016–2025 (USD Billion)
51. Rest of Latin America Anticoagulants market revenue, by Route of Administration, 2016–2025 (USD Billion)
52. Rest of Latin America Anticoagulants market revenue, by Application, 2016–2025 (USD Billion)
53. The Middle East and Africa Anticoagulants market revenue, by Drug Class, 2016–2025 (USD Billion)
54. The Middle East and Africa Anticoagulants market revenue, by Route of Administration, 2016–2025 (USD Billion)
55. The Middle East and Africa Anticoagulants market revenue, by Application, 2016–2025 (USD Billion)
Methodology
FrequentlyAsked Questions
Anticoagulants are a class of medications used to prevent the formation of blood clots or to treat existing clots.
According to study, the Anticoagulants market size was worth around USD 43.28 billion in 2023 and is predicted to grow to around USD 97.16 billion by 2032.
The CAGR value of Anticoagulants market is expected to be around 9.4% during 2024-2032.
North America has been leading the Anticoagulants market and is anticipated to continue on the dominant position in the years to come.
The Anticoagulants market is led by players like Bayer AG, Aspen Holdings, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Limited, Bristol-Myers Squibb Company, GlaxoSmithKline, Pfizer Inc., Sanofi S.A., Johnson & Johnson, and Portola Pharmaceuticals Inc., among others.
Choose License Type
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed